Modeling Parkinson's Disease With the Alpha-Synuclein Protein.
Gómez-Benito M, Granado N, García-Sanz P, Michel A, Dumoulin M, Moratalla R. · 2020
Read Modeling Parkinson's Disease With the Alpha-Synuclein Protein. by Gómez-Benito M, Granado N, García-Sanz P, Michel A, Dumoulin M, Moratalla R. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7191035.txt.
Description
Gómez-Benito and co-authors review animal models of Parkinson's disease built around alpha-synuclein. Their article appeared in Frontiers in Pharmacology. This protein clumps into Lewy bodies in the Parkinson's brain. Dopamine-producing cells in the substantia nigra die off. Mutations in the protein's gene cause inherited forms of the disease.
Good models must copy both the cell loss and the spreading clumps. The review covers models that add the protein by gene or injection. It tracks how clumps appear and neurons decline over time. Some models show gradual loss of dopamine markers after injection. Others miss parts of the human picture. The authors judge each model's strengths and gaps. Such models remain central to testing future treatments.
Catalog record
| CREATOR | Gómez-Benito M, Granado N, García-Sanz P, Michel A, Dumoulin M, Moratalla R. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 88 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |